Animal-Assisted Therapy Combined With Standard Rehabilitation for Motor Recovery in Dementia Patients in a Medical and Rehabilitation Care Unit
RéMédi - A
Impact of a Combined Rehabilitation and Animal-Assisted Therapy Approach on the Recovery of Motor Abilities in Patients With Dementia Hospitalized in a Medical and Rehabilitation Care Unit
1 other identifier
interventional
32
1 country
1
Brief Summary
The goal of this randomized study is to find out if animal-assisted therapy (AAT) - a structured program where trained animals take part in care sessions guided by health professionals - can help improve movement abilities in older adults with dementia or memory-related conditions who are staying in a medical rehabilitation unit. The main questions this study aims to answer are:
- Can adding animal-assisted therapy to standard rehabilitation improve participants' movement and motor abilities better than standard rehabilitation alone?
- Can this combined approach help participants stay more independent in daily activities?
- Can this combined approach improve participants' quality of life?
- Can this combined approach reduce the risk of falls? Researchers will compare two groups:
- Group 1 (experimental): Standard rehabilitation + animal-assisted therapy sessions with a trained dog and/or rabbits
- Group 2 (control): Standard rehabilitation alone Both groups attend 2 one-hour rehabilitation sessions per week for 4 weeks. Participants will:
- Complete movement and daily-life ability tests at the start and end of the study
- Attend 8 rehabilitation sessions (over 4 weeks)
- Participants in the animal therapy group will interact with a trained dog and/or rabbits during sessions, guided by a certified nurse-animal therapist, a psychomotor therapist, and a nursing assistant
- Be assessed at the end of the 4-week program (Week 6) to measure any changes in motor abilities, independence, quality of life, and fall risk
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 23, 2026
CompletedFirst Posted
Study publicly available on registry
July 28, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
Study Completion
Last participant's last visit for all outcomes
December 1, 2027
July 28, 2026
July 1, 2026
1.2 years
July 23, 2026
July 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline in Motor Abilities as Assessed by the Geronto-Psychomotor Examination (EGP) at Week 6
The EGP (Examen Géronto-Psychomoteur) is a standardized French geriatric psychomotor assessment tool evaluating items 1 to 10.5 across domains including global motor function, balance and posture, fine motor skills and praxis, body schema, and sensory-motor function. Items are scored on discrete scales and combined to produce a composite psychomotor score. Higher scores indicate better psychomotor functioning. Scoring range per protocol assessment tools (Annex XIII). MCID not yet established in this population
Baseline (Day 0, Week 1) and End of Study (Week 6, ± 7 days)
Secondary Outcomes (5)
Change from Baseline in Functional Autonomy as Assessed by the Instrumental Activities of Daily Living (IADL) Scale at Week 6
Baseline (Day 0, Week 1) and End of Study (Week 6, ± 7 days)
Change from Baseline in Quality of Life as Assessed by the Alzheimer's Disease-Related Quality of Life (ADRQL) Scale at Week 6
Baseline (Day 0, Week 1) and End of Study (Week 6, ± 7 days)
Change from Baseline in Fall Risk as Assessed by the Tinetti Performance-Oriented Mobility Assessment at Week 6
Baseline (Day 0, Week 1) and End of Study (Week 6, ± 7 days)
Number of Psychomotor Rehabilitation or Animal-Assisted Therapy Sessions Attended Over the 4-Week Rehabilitation Period
Weeks 2 to 5 (End of 4-week rehabilitation period)
Change in Emotional, Social, and Motor Behavioral Dimensions as Assessed by a Qualitative Behavioral Grid at Each Rehabilitation Session (Weeks 2-5)
At each of the 8 rehabilitation sessions (Weeks 2 to 5)
Study Arms (2)
Group Experimental : Standard Rehabilitation Combined with Animal-Assisted Therapy
EXPERIMENTALStandard rehabilitation program (physiotherapy, occupational therapy, adapted physical activity) plus structured animal-assisted therapy (AAT) sessions integrating psychomotor rehabilitation. Sessions led by a certified nurse-animal therapist, a psychomotor therapist, and a nursing assistant. Frequency: 2 sessions × 1 hour/week for 4 weeks (8 sessions total, max 2 participants/session). Animals: 1 dog (golden retriever/malinois cross) and/or 2-4 rabbits. Sessions address global motor function, balance, fine motor skills, body schema, and sensory stimulation.
Group Control : Standard Rehabilitation
ACTIVE COMPARATORStandard rehabilitation program as delivered at Institut Médical de Sologne (IMDS), including physiotherapy, occupational therapy, adapted physical activity, and group psychomotor rehabilitation. Psychomotor therapy: 2 group sessions × 1 hour/week for 4 weeks (8 sessions total). Sessions cover fine and manual motor skills, static and dynamic coordination, posture, muscle tone, and praxis. This represents the recognized standard of care for patients with dementia in a French medical and rehabilitation care unit.
Interventions
Structured AAT sessions integrating psychomotor rehabilitation, delivered by a certified nurse-animal therapist, psychomotor therapist, and nursing assistant. Frequency: 2 sessions × 1 hour/week for 4 weeks (8 sessions). Individualized therapeutic motor objectives defined before first session. Each session: (1) welcome/emotions check-in; (2) animal introduction and contact; (3) motor exercises across 5 domains: global motor function, balance/posture, fine motor skills/praxis, body schema, sensory-motor stimulation; (4) session debrief. Animals: 1 dog and/or 2-4 rabbits. Maximum 2 participants per session.
Group psychomotor rehabilitation sessions led by the establishment's certified psychomotor therapist. Frequency: 2 group sessions × 1 hour/week for 4 weeks (8 sessions total). Sessions address fine and manual motor skills, static and dynamic coordination, posture, muscle tone, and praxis. Participants also receive individualized physiotherapy, occupational therapy, and adapted physical activity as part of standard geriatric rehabilitation care.
Eligibility Criteria
You may qualify if:
- Hospitalized in the geriatric medical and rehabilitation ward (SMR) of Institut Médical de Sologne (IMDS)
- Diagnosed dementia or confirmed cognitive decline, shown by a score between 15 and 24 on the Mini-Mental State Examination (MMSE - a short standardized test of memory and thinking)
- Has active motor rehabilitation goals (identified need to improve movement abilities during hospitalization)
- Participant and/or their legal guardian, trusted person (personne de confiance), curator, or family member has provided written consent to participate in the study
- Affiliated to a French social security scheme
You may not qualify if:
- Known allergy to the animals used in the animal-assisted therapy sessions (dog, rabbits)
- Fear of animals
- History of aggressive behavior toward animals
- Concomitant psychiatric disorders
- Needs only a stimulation and/or skills maintenance approach (no active motor rehabilitation goals)
- Currently enrolled in another interventional research study
- (Note: A participant who was previously enrolled in another interventional study may join RÉMÉDI-A once their participation in the prior study has ended, without a washout period, provided all eligibility criteria are met.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- LNA SANTElead
Study Sites (1)
Institut Médical de Sologne LNA Santé
Lamotte-Beuvron, 41600, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rodrigue DR SAGBO
Institut Médical de Sologne LNA Santé
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 23, 2026
First Posted
July 28, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
July 28, 2026
Record last verified: 2026-07